Tuesday, March 3, 2026
spot_img
HomeNews

News

PacBio Announces New Nanobind Extraction Kits to Enable High-Throughput Workflows with Revio and Sequel Systems

PacBio, a leading developer of high-quality, highly accurate sequencing solutions,  announced the availability of its new high-throughput (HT) Nanobind DNA Extraction kits, another key...

New Survey Finds Millennials and Gen Xers Not Following Safe Sun Habits, Increasing Risk of Nonmelanoma Skin Cancer

In a new survey of 1,000 millennials and 1,000 Gen Xers, 75% of respondents said that while they are mindful of their sun exposure, only 19%...

Astrocyte Announces Initiation of an Extended Infusion Phase 1B Study of AST-004 for Stroke and Traumatic Brain Injuries

Astrocyte Pharmaceuticals Inc, a drug discovery and development company advancing novel cerebroprotective therapeutics for patients with brain injuries, is pleased to announce the initiation...

Marin Cancer Care and House Rx Partner for Collaborative Care Delivery

House Rx and Marin Cancer Care announced a partnership to bring House Rx's point-of-care specialty medicine dispensing into Marin Cancer Care's care delivery model. Called 'medically integrated dispensing,'...

U.S. Neurologists Cautiously Optimistic Following Accelerated Approval and Launch of Eisai/Biogen’s Leqembi for Early Alzheimer’s Disease, According to Spherix Global Insights

With the accelerated approval on January 6, 2023 for early Alzheimer's disease, Eisai/Biogen's Leqembi became only the second approved disease-modifying therapy (DMT) for early Alzheimer's...

Hot Topics

spot_img